MYOTONIC DYSTROPHY TYPE 1
Clinical trials for MYOTONIC DYSTROPHY TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new MYOTONIC DYSTROPHY TYPE 1 trials appear
Sign up with your email to follow new studies for MYOTONIC DYSTROPHY TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for DM1: Long-Term trial of AOC 1001 begins
Disease control ENROLLING_BY_INVITATIONThis study is for people with myotonic dystrophy type 1 (DM1) who have already taken part in earlier AOC 1001 trials. It aims to see if the drug is safe and works well over a longer period. About 230 adults will receive the medicine by IV and be monitored for side effects and ben…
Matched conditions: MYOTONIC DYSTROPHY TYPE 1
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Why do people with myotonic dystrophy fall? new study investigates
Knowledge-focused OngoingThis study measures how often people with myotonic dystrophy type 1 fall and what factors affect their balance. Researchers will also look at fear of falling and leg muscle strength. The goal is to better understand fall risks in this condition. About 41 adults aged 18 to 60 will…
Matched conditions: MYOTONIC DYSTROPHY TYPE 1
Sponsor: Antalya Training and Research Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC